Trial intelligence / Profile preview

Adjunctive Misoprostol for Blood Loss at Vaginal Delivery

NCT02411916Completed

Sponsor
NYC Health + Hospitals
Start
Mar 2012
Primary completion
Feb 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of misoprostol in postpartum hemorrhage (PPH) (2 arms), sponsored by NYC Health + Hospitals. Primary endpoint: Change in Hemoglobin. Started Mar 2012; status: completed.

02

Drugs

misoprostol
03

Conditions

postpartum hemorrhage (PPH)

Beyond the preview

Go deeper on NCT02411916.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02411916.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call